Find a laboratory at the Crick.
Opportunities for postdoctoral clinicians to consolidate their research experience.
We collaborate with local residents, community organisations and partners
Discover and make
Exhibition entry: Best for families with primary school and early secondary school aged children
Crick researchers are working at the forefront of the scientific response to answer some of the most urgent questions about the SARS-CoV-2 pathogen, from how we can improve testing, to why it’s deadly in some people but causes no symptoms in others.
The Francis Crick Institute is working at the forefront of the scientific response to coronavirus, volunteering expertise and facilities to help tackle the COVID-19 pandemic.
Scientists from global biopharmaceutical company MSD will come to the Crick next year to tackle a range of conditions associated with ageing such as dementia and Parkinson’s disease.
Artios Pharma Limited, a biotech company established with the help and expertise of Francis Crick Institute scientist Simon Boulton, has secured an additional $86m (£65m) to advance its first-in-class small molecule DNA repair programmes into the clinic.
Our scientists care about the impact of their work - the Crick has a unique culture of translation where innovation and entrepreneurship is encouraged and celebrated.